Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,040.00
+40.00 (1.00%)
At close: Jan 29, 2026
-13.86%
Market Cap394.66B
Revenue (ttm)184.38B +32.7%
Net Income9.74B
EPS130.59
Shares Out98.66M
PE Ratio30.63
Forward PEn/a
Dividend50.00 (1.27%)
Ex-Dividend DateNov 4, 2025
Volume741,321
Average Volume462,630
Open4,000.00
Previous Close4,000.00
Day's Range3,900.00 - 4,055.00
52-Week Range3,200.00 - 5,160.00
Beta0.58
RSI59.21
Earnings DateMar 16, 2026

About Bukwang Pharmaceutical

Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication... [Read more]

Sector Healthcare
Founded 1960
Employees 615
Stock Exchange Korea Stock Exchange
Ticker Symbol 003000
Full Company Profile

Financial Performance

In 2024, Bukwang Pharmaceutical's revenue was 160.09 billion, an increase of 27.13% compared to the previous year's 125.93 billion. Losses were -2.64 billion, -91.57% less than in 2023.

Financial Statements